Cyclosporin a and Doxorubicin-Ifosfamide in Resistant Solid Tumours: A Phase I and an Immunological Study

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1995.503
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Phase I Study of Intravenous Liposomal Daunorubicin (DaunoXome) in Paediatric Patients With Relapsed or Resistant Solid Tumours

British Journal of Cancer
Cancer ResearchOncology
2006English

A Phase I Study of E7080, a Multitargeted Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Tumours

British Journal of Cancer
Cancer ResearchOncology
2012English

A Phase I Study of Pemetrexed (LY231514) Supplemented With Folate and Vitamin B12 in Japanese Patients With Solid Tumours

British Journal of Cancer
Cancer ResearchOncology
2006English

A Multi-Arm Phase I Dose Escalating Study of an Oral NOTCH Inhibitor BMS-986115 in Patients With Advanced Solid Tumours

Investigational New Drugs
OncologyPharmacology
2018English

Phase I Study of TAS-102 Treatment in Japanese Patients With Advanced Solid Tumours

British Journal of Cancer
Cancer ResearchOncology
2012English

Phase I and Pharmacokinetic Study of D-Verapamil and Doxorubicin

British Journal of Cancer
Cancer ResearchOncology
1991English

A Phase I Study of the HDM2 Antagonist SAR405838 Combined With the MEK Inhibitor Pimasertib in Patients With Advanced Solid Tumours

British Journal of Cancer
Cancer ResearchOncology
2018English

A Phase I Trial of Ispinesib, a Kinesin Spindle Protein Inhibitor, With Docetaxel in Patients With Advanced Solid Tumours

British Journal of Cancer
Cancer ResearchOncology
2008English

Phase I Study to Assess the Safety and Tolerability of Olaparib in Combination With Bevacizumab in Patients With Advanced Solid Tumours

British Journal of Cancer
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy